Elacridar tilonium Bromide Saracatinib potently inhibits the proliferation

Saracatinib potently inhibits the proliferation of Src3T3 mouse fibroblasts and demonstrates variable antiproliferative activity in a range of human cancer cell lines containing endogenous Src

[1] The active substance is tenofovir

Pemirolast potently attenuates paclitaxel hypersensitivity reactions through inhibition of the release of sensory neuropeptides in rats

HeLa and HT-29 cells) treatment significantly increases the cytotoxicity of DNA damage

and an inhibitor of WWP1 (WW domain-containing ubiquitin E3 ligase 1)

Elacridar tilonium Bromide Saracatinib potently inhibits the proliferationElacridar, also known as GF120918A, is a P glycoprotein (P gp) inhibitor, and has been used both in vitro and in vivo as a tool inhibitor of P glycoprotein (Pgp) to investigate the role of transporters in the disposition of various test molecules. In vitro, GF120918A demonstrated high plasma protein binding across species, although a definitive protein binding evaluation was precluded by poor recovery, particularly in buffer and in mouse, rat, and dog